Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-04-12Clinical Trial Update: Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event. [Phase 4]
Phase 4 trial evaluating induction therapy with a single high-dose intravenous methotrexate with leucovorin rescue prior to AVONEX treatment…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis [Phase 4]
A Phase 4 trial update assessing combination therapy with Avonex (interferon beta-1a) and high-dose intravenous methotrexate for multiple sc…
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple Sclerosis
The clinical trial update reports a completed study investigating whether optical coherence tomography can detect retinal microvascular chan…
-
CLINICAL_TRIALS withdrawal · 2018-04-12Clinical Trial Update: Progression of Cognitive and Physical Symptoms in Multiple Sclerosis
The clinical trial NCT00922831 evaluating progression of cognitive and physical symptoms in multiple sclerosis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Detecting and Addressing Preclinical Disability
McMaster University reports a completed clinical trial update on detecting and addressing preclinical disability. The study encompasses pati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Evaluation of a Web-Based Fall Prevention Program on People With Multiple Sclerosis [NA]
A clinical trial evaluating a web-based fall prevention program for people with Multiple Sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: Mindfulness-based Stress Reduction for Multiple Sclerosis [NA]
This clinical trial update indicates that the Mindfulness-based Stress Reduction study for multiple sclerosis has completed. No results are …
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Methylphenidate to Improve Balance and Walking in MS [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial update reports results evaluating methylphenidate to improve balance and walking in people with multiple sc…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis
ClinicalTrials.gov reports a noninterventional study sponsored by Bayer evaluating cognitive function and physical activity in people with M…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: The Impact of Positive Mental Training in Multiple Sclerosis [NA]
This update reports on the completion of a clinical trial evaluating positive mental training for individuals with multiple sclerosis and ps…
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Motor Imagery Training in Persons With Multiple Sclerosis [NA]
Clinical trial update indicating a motor imagery training study in persons with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Enhance Wellness for Individuals With Long-Term Physical Disabilities [NA]
Clinical trial update shows the study on enhancing wellness for individuals with long-term physical disabilities has completed. The trial co…
-
CLINICAL_TRIALS research · 2018-03-22Clinical Trial Update: Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients [Phase 4]
Phase 4 clinical trial update examining indirect neuroprotective effects of Tecfidera (dimethyl fumarate) in relapsing-remitting and progres…
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple Sclerosis [Phase 1]
A Phase 1 trial investigating intrathecal administration of autologous mesenchymal stem cell-derived neural progenitors (MSC-NP) for multipl…
-
CLINICAL_TRIALS trial_result · 2018-03-13Clinical Trial Update: Anesthetic Topical Adhesive (Synera™) to Reduce Injection Pain With Subcutaneous Multiple Sclerosis Medications [Phase 4]
A Phase 4 clinical trial evaluated the anesthetic topical adhesive Synera to reduce pain from subcutaneous injections of multiple sclerosis …
-
CLINICAL_TRIALS research · 2018-03-08Clinical Trial Update: Validation of Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) [NA]
A clinical trial validating the Brief Computerized Cognitive Assessment in people with Multiple Sclerosis (BCCAMS) has completed.
-
EMA safety_alert · 2018-03-07EMA recommends immediate suspension and recall of multiple sclerosis medicine Zinbryta
EMA recommends immediate suspension and recall of Zinbryta due to safety concerns, advising temporary withdrawal from the market.
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis [Phase 1, Phase 2]
An update on a completed Phase 1/2 trial evaluating autologous mesenchymal stem cell transplantation for multiple sclerosis. The report summ…
-
EMA safety_alert · 2018-03-02EMA urgently reviewing multiple sclerosis medicine Zinbryta following cases of inflammatory brain disorders
EMA is urgently reviewing the multiple sclerosis medicine Zinbryta due to reported cases of inflammatory brain disorders.
-
CLINICAL_TRIALS trial_result · 2018-03-02Clinical Trial Update: Study of VSN16R for the Treatment of Spasticity in Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial evaluating VSN16R for spasticity in people with multiple sclerosis has completed. The sponsor is Canbex Therapeutic…
-
CLINICAL_TRIALS trial_result · 2018-03-01Clinical Trial Update: Reproductibility of Cystometry in Multiple Sclerosis Patient
A completed trial from Pierre and Marie Curie University assessed the reproducibility of cystometry measurements in patients with multiple s…
-
FDA approval · 2018-02-12FDA Approved: GLATOPA — Original Application (Sandoz Inc)
The FDA approved GLATOPA as an Original Application for glatiramer acetate by Sandoz Inc, a generic version of Copaxone. It is indicated for…
-
EMA withdrawal · 2018-02-06EMA Application withdrawn: Qizenday — Medday Pharmaceuticals
EMA withdrawal of the Qizenday application from Medday Pharmaceuticals for multiple sclerosis.
-
FDA approval · 2018-01-23FDA Approved: COPAXONE — Supplemental Application (Teva Neuroscience, Inc.)
The FDA approved a supplemental application for COPAXONE (glatiramer acetate) submitted by Teva Neuroscience, Inc.
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY [Phase 4]
Phase 4 single-center open-label trial examining Preparation H for reducing erythema in relapsing multiple sclerosis patients treated with P…